Showing results (41-50 of 1,986) with videos related to
Sort By:
Pageof 199
Pigment Cell & Melanoma Research|March 16, 2013
Selective RAF inhibitor impairs ERK1/2 phosphorylation and growth in mutant NRAS, vemurafenib-resistant melanoma cellsKaitlyn Le, Erik S Blomain, Ulrich Rodeck, et al.The Journal of Biological Chemistry|August 14, 2015
Fibroblast-derived neuregulin 1 promotes compensatory ErbB3 receptor signaling in mutant BRAF melanomaClaudia Capparelli, Sheera Rosenbaum, Adam C Berger, et al.Cancers|October 14, 2022
Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?Imène Krossa, Thomas Strub, Andrew E Aplin, et al.Journal of Cell Science|June 22, 2002
Cell adhesion differentially regulates the nucleocytoplasmic distribution of active MAP kinasesAndrew E Aplin, Brian P Hogan, Jeannie Tomeu, et al.Pigment Cell & Melanoma Research|January 16, 2014
Inhibition of mutant BRAF splice variant signaling by next-generation, selective RAF inhibitorsKevin J Basile, Kaitlyn Le, Edward J Hartsough, et al.Molecular Cancer Research : MCR|April 18, 2009
Mcl-1 is required for melanoma cell resistance to anoikisKaren Boisvert-Adamo, Whitney Longmate, Ethan V Abel, et al.Molecular Cancer Research : MCR|July 26, 2014
FOXD3 modulates migration through direct transcriptional repression of TWIST1 in melanomaMichele B Weiss, Ethan V Abel, Neda Dadpey, et al.Cell Reports|November 8, 2018
BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK AssociationMichael J Vido, Kaitlyn Le, Edward J Hartsough, et al.The Journal of Biological Chemistry|July 4, 2006
Cyclin D3 expression in melanoma cells is regulated by adhesion-dependent phosphatidylinositol 3-kinase signaling and contributes to G1-S progressionLaurie S Spofford, Ethan V Abel, Karen Boisvert-Adamo, et al.Iscience|August 28, 2023
Gene signature reveals decreased SOX10-dependent transcripts in malignant cells from immune checkpoint inhibitor-resistant cutaneous melanomasTimothy J Purwin, Signe Caksa, Ahmet Sacan, et al.Pageof 199